This announcement is a separate document:
浙江海正药业股份有限公司关于艾曲泊帕乙醇胺原料药获得《化学原料药上市申请批准通知书》的公告
Announcement from Zhejiang Hisun Pharmaceutical Co., Ltd. regarding the approval of the listing application of Epobispar Emine Active Pharmaceutical Ingredient in the 'Notification of Approval of Chemical Raw Materials for Market Application'
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated